Dataset Information

What information and the extent of information research participants need in informed consent forms: a multi-country survey.

ABSTRACT: BACKGROUND:The use of lengthy, detailed, and complex informed consent forms (ICFs) is of paramount concern in biomedical research as it may not truly promote the rights and interests of research participants. The extent of information in ICFs has been the subject of debates for decades; however, no clear guidance is given. Thus, the objective of this study was to determine the perspectives of research participants about the type and extent of information they need when they are invited to participate in biomedical research. METHODS:This multi-center, cross-sectional, descriptive survey was conducted at 54 study sites in seven Asia-Pacific countries. A modified Likert-scale questionnaire was used to determine the importance of each element in the ICF among research participants of a biomedical study, with an anchored rating scale from 1 (not important) to 5 (very important). RESULTS:Of the 2484 questionnaires distributed, 2113 (85.1%) were returned. The majority of respondents considered most elements required in the ICF to be 'moderately important' to 'very important' for their decision making (mean score, ranging from 3.58 to 4.47). Major foreseeable risk, direct benefit, and common adverse effects of the intervention were considered to be of most concerned elements in the ICF (mean score?=?4.47, 4.47, and 4.45, respectively). CONCLUSIONS:Research participants would like to be informed of the ICF elements required by ethical guidelines and regulations; however, the importance of each element varied, e.g., risk and benefit associated with research participants were considered to be more important than the general nature or technical details of research. Using a participant-oriented approach by providing more details of the participant-interested elements while avoiding unnecessarily lengthy details of other less important elements would enhance the quality of the ICF.

SUBMITTER: Karbwang J

PROVIDER: S-EPMC6139128 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

What information and the extent of information research participants need in informed consent forms: a multi-country survey.

Karbwang Juntra J Koonrungsesomboon Nut N Torres Cristina E CE Jimenez Edlyn B EB Kaur Gurpreet G Mathur Roli R Sholikhah Eti N EN Wanigatunge Chandanie C Wong Chih-Shung CS Yimtae Kwanchanok K Abdul Malek Murnilina M Ahamad Fouzi Liyana L Ali Aisyah A Chan Beng Z BZ Chandratilake Madawa M Chiew Shoen C SC Chin Melvyn Y C MYC Gamage Manori M Gitek Irene I Hakimi Mohammad M Hussin Narwani N Jamil Mohd F A MFA Janarsan Pavithra P Julia Madarina M Kanungo Suman S Karunanayake Panduka P Kollanthavelu Sattian S Kong Kian K KK Kueh Bing-Ling BL Kulkarni Ragini R Kumaran Paul P PP Kumarasiri Ranjith R Lim Wei H WH Lim Xin J XJ Mahmud Fatihah F Mantaring Jacinto B V JBV Md Ali Siti M SM Mohd Noor Nurain N Muhunthan Kopalasuntharam K Nagandran Elanngovan E Noor Maisarah M Ooi Kim H KH Pradeepan Jebananthy A JA Sadewa Ahmad H AH Samaranayake Nilakshi N Sri Ranganathan Shalini S Subasingha Wasanthi W Subramaniam Sivasangari S Sulaiman Nadirah N Tay Ju F JF Teng Leh H LH Tew Mei M MM Tharavanij Thipaporn T Tok Peter S K PSK Weeratna Jayanie J Wibawa Tri T Wickremasinghe Renu R Wongwai Phanthipha P Yadav Subhash S

BMC medical ethics 20180915 1

<h4>Background</h4>The use of lengthy, detailed, and complex informed consent forms (ICFs) is of paramount concern in biomedical research as it may not truly promote the rights and interests of research participants. The extent of information in ICFs has been the subject of debates for decades; however, no clear guidance is given. Thus, the objective of this study was to determine the perspectives of research participants about the type and extent of information they need when they are invited t ...[more]

PMID: 30219106

Similar Datasets

Project description:Cognitive impairment is a characteristic of schizophrenia. This impairment may affect the retention of information required for ongoing knowledgeable participation in clinical trials. This study monitored retention of study-related knowledge-including assessment of therapeutic misconception-in people with stable, DSM-IV schizophrenia during participation in placebo-controlled clinical trials of adjunctive agents. Stability was defined as being on an antipsychotic with no change in medication or dose over the previous 4 weeks.This longitudinal study assessed retention of clinical trial-related consent information. Individuals enrolling in 1 of 8 clinical trials were approached for participation. Participants came from research clinics and community mental health centers. At baseline, clinical trial consent forms were reviewed and study knowledge assessed. Participants were randomized to follow-up assessments at weeks 1, 4, and 8; weeks 4 and 8; or at week 8 only. Clinical trial consent forms were not rereviewed at any follow-up visit.Fifty-nine participants were enrolled; analysis included 52 participants with at least 1 follow-up visit. Study knowledge did not decrease meaningfully in any group. Therapeutic misconception was not observed in participants during the study. The group assessed most frequently demonstrated significant improvement over baseline (t44 = 3.43, P = .001). Retention of study knowledge was not related to symptoms but had a weak correlation with cognitive capacity (R = 0.28, P = .07). Performance did not differ between participants from research clinics and those from community mental health centers.Clinically stable people with schizophrenia enrolling in a placebo-controlled adjunctive medication study, once determined to have capacity to consent to a clinical trial, retained appropriate study knowledge for at least 8 weeks. In the absence of a specific reason to suspect a loss of decisional capacity, there appears to be no need to routinely reevaluate participants during this type of clinical trial.

Project description:BackgroundThe process of informed consent for enrolment to a clinical research study can be complex for both participants and research staff. Challenges include respecting the potential participant's autonomy and information needs while simultaneously providing adequate information to enable an informed decision. Qualitative research with small sample sizes has added to our understanding of these challenges. However, there is value in garnering the perspectives of research participants and staff across larger samples to explore the impact of contextual factors (time spent, the timing of the discussion and the setting), on the informed consent process.MethodsResearch staff and research participants from Ireland and the UK were invited to complete an anonymous survey by post or online (research participants) and online (research staff). The surveys aimed to quantify the perceptions of research participants and staff regarding some contextual factors about the process of informed consent. The survey, which contained 14 and 16 multiple choice questions for research participants and staff respectively, was analysed using descriptive statistics. Both surveys included one optional, open-ended question, which were analysed thematically.ResultsResearch participants (169) and research staff (115) completed the survey. Research participants were predominantly positive about the informed consent process but highlighted the importance of having sufficient time and the value of providing follow-up once the study concludes, e.g. providing results to participants. Most staff (74.4%) staff reported that they felt very confident or confident facilitating informed consent discussions, but 63% felt information leaflets were too long and/or complicated, 56% were concerned about whether participants had understood complex information and 40% felt that time constraints were a barrier. A dominant theme from the open-ended responses to the staff survey was the importance of adequate time and resources.ConclusionsResearch participants in this study were overwhelmingly positive about their experience of the informed consent process. However, research staff expressed concern about how much participants have understood and studies of patient comprehension of research study information would seem to confirm these fears. This study highlights the importance of allocating adequate time to informed consent discussions, and research staff could consider using Teach Back techniques.Trial registrationNot applicable.

Dataset Information

What information and the extent of information research participants need in informed consent forms: a multi-country survey.

Publications

What information and the extent of information research participants need in informed consent forms: a multi-country survey.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets